Dept of Dermatology, Brigham and Women's Hospital, Harvard Medical School, United States
Disclosure information not submitted.
A scalable approach to assess the safety of novel systemic treatments for atopic dermatitis in clinical practice: First analysis cycle of the ADVANCES sequential monitoring system
Monday, August 26, 20241:45 PM – 2:00 PM CEST
